Bavari S - Search Results

1

A systematic screen of FDA-approved drugs for inhibitors of biological threat agents.

Madrid PB, Chopra S, Manger ID, Gilfillan L, Keepers TR, Shurtleff AC, Green CE, Iyer LV, Dilks HH, Davey RA, Kolokoltsov AA, Carrion R Jr, Patterson JL, Bavari S, Panchal RG, Warren TK, Wells JB, Moos WH, Burke RL, Tanga MJ. Madrid PB, et al. Among authors: bavari s. PLoS One. 2013;8(4):e60579. doi: 10.1371/journal.pone.0060579. Epub 2013 Apr 5. PLoS One. 2013. PMID: 23577127 Free PMC article.

2

Evaluation of Ebola Virus Inhibitors for Drug Repurposing.

Madrid PB, Panchal RG, Warren TK, Shurtleff AC, Endsley AN, Green CE, Kolokoltsov A, Davey R, Manger ID, Gilfillan L, Bavari S, Tanga MJ. Madrid PB, et al. Among authors: bavari s. ACS Infect Dis. 2015 Jul 10;1(7):317-26. doi: 10.1021/acsinfecdis.5b00030. Epub 2015 May 11. ACS Infect Dis. 2015. PMID: 27622822

3

Advanced morpholino oligomers: a novel approach to antiviral therapy.

Warren TK, Shurtleff AC, Bavari S. Warren TK, et al. Among authors: bavari s. Antiviral Res. 2012 Apr;94(1):80-8. doi: 10.1016/j.antiviral.2012.02.004. Epub 2012 Feb 14. Antiviral Res. 2012. PMID: 22353544 Free PMC article. Review.

4

Nonhuman primates as models for the discovery and development of ebolavirus therapeutics.

Shurtleff AC, Warren TK, Bavari S. Shurtleff AC, et al. Among authors: bavari s. Expert Opin Drug Discov. 2011 Mar;6(3):233-50. doi: 10.1517/17460441.2011.554815. Expert Opin Drug Discov. 2011. PMID: 22647202

5

Therapeutics for filovirus infection: traditional approaches and progress towards in silico drug design.

Shurtleff AC, Nguyen TL, Kingery DA, Bavari S. Shurtleff AC, et al. Among authors: bavari s. Expert Opin Drug Discov. 2012 Oct;7(10):935-54. doi: 10.1517/17460441.2012.714364. Epub 2012 Aug 8. Expert Opin Drug Discov. 2012. PMID: 22873527 Review.

6

Antisense treatments for biothreat agents.

Warfield KL, Panchal RG, Aman MJ, Bavari S. Warfield KL, et al. Among authors: bavari s. Curr Opin Mol Ther. 2006 Apr;8(2):93-103. Curr Opin Mol Ther. 2006. PMID: 16610760 Review.

7

Identification of an antioxidant small-molecule with broad-spectrum antiviral activity.

Panchal RG, Reid SP, Tran JP, Bergeron AA, Wells J, Kota KP, Aman J, Bavari S. Panchal RG, et al. Among authors: bavari s. Antiviral Res. 2012 Jan;93(1):23-9. doi: 10.1016/j.antiviral.2011.10.011. Epub 2011 Oct 18. Antiviral Res. 2012. PMID: 22027648

8

Peptide conjugated phosphorodiamidate morpholino oligomers increase survival of mice challenged with Ames Bacillus anthracis.

Panchal RG, Geller BL, Mellbye B, Lane D, Iversen PL, Bavari S. Panchal RG, et al. Among authors: bavari s. Nucleic Acid Ther. 2012 Oct;22(5):316-22. doi: 10.1089/nat.2012.0362. Epub 2012 Sep 14. Nucleic Acid Ther. 2012. PMID: 22978365 Free PMC article.

9

Shedding light on filovirus infection with high-content imaging.

Pegoraro G, Bavari S, Panchal RG. Pegoraro G, et al. Among authors: bavari s. Viruses. 2012 Aug;4(8):1354-71. doi: 10.3390/v4081354. Epub 2012 Aug 23. Viruses. 2012. PMID: 23012631 Free PMC article. Review.

10

Discovery and early development of AVI-7537 and AVI-7288 for the treatment of Ebola virus and Marburg virus infections.

Iversen PL, Warren TK, Wells JB, Garza NL, Mourich DV, Welch LS, Panchal RG, Bavari S. Iversen PL, et al. Among authors: bavari s. Viruses. 2012 Nov 6;4(11):2806-30. doi: 10.3390/v4112806. Viruses. 2012. PMID: 23202506 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

325 results

Search Page

Filters